Stock Comparison Charts
Metric | ||||
---|---|---|---|---|
Stock Details | ||||
Current Price | 3213.6 | 5446.5 | 5216.5 | 236.0 |
Previous Close | 3243.8 | 5517.0 | 5183.5 | 237.15 |
Open | 3243.8 | 5509.0 | 5213.0 | 238.6 |
Day Low | 3203.0 | 5423.0 | 5184.0 | 235.1 |
Day High | 3243.8 | 5514.0 | 5219.0 | 238.6 |
Market Cap | 550756483072.0 | 263571931136.0 | 124122447872.0 | 21362980864.0 |
P/E Ratio | 58.62 | 32.47 | 71.37 | 28.92 |
Forward P/E | 55.5 | 32.54 | 45.24 | N/A |
Earnings Per Share | 54.82 | 167.72 | 73.09 | 8.16 |
Dividend Yield (%) | 1.24 | 0.62 | 0.97 | 0.16 |
Beta | 0.04 | 0.18 | N/A | 0.7 |
EBITDA | 11527068672.0 | 7402299904.0 | 2492750080.0 | 1389912960.0 |
Book Value | 115.19 | 921.88 | 118.54 | 72.15 |
Debt to Equity | 0.51 | 2.57 | 7.44 | 48.58 |
ROCE (%) | N/A | N/A | N/A | N/A |
ROE (%) | N/A | N/A | N/A | N/A |
Face Value | N/A | N/A | N/A | N/A |
Price to Book | 27.9 | 5.91 | 44.01 | 3.27 |
Performance | ||||
1Y Return (%) | 2708.08 | 1167.45 | 571.02 | -285.91 |
About Company | ||||
Founded Year | N/A | N/A | N/A | N/A |
Employees | 3113 | N/A | 583 | N/A |
Website | Live Website of GLAXO | Live Website of PFIZER | Live Website of SANOFICONR | Live Website of SMSPHARMA |
Company Overviews & Financial Position
Review detailed company profiles, including business summaries and key insights into their balance sheet and company financial position to aid in buying or selling decisions.
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. It provides vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease; Boostrix for immunization against diphtheria, tetanus and pertussis; Fluarix Tetra for the prevention of influenza disease; Varilrix for active immunization against varicella, and Shingrix for prevention of herpes zoster and post-herpetic neuralgia. It also offers specialty medicines, such as NUCALA for severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome; and TRELEGY ELLIPTA for treating chronic obstructive pulmonary disease. In addition, the company offers general medicines, including AUGMENTIN and CEFTUM, an oral antibiotic to treat bacterial infections; CobadexCZS to treat mineral and vitamins deficiency states in adult patients; Flutivate, a skin cream for adults, children and infants; Tenovate to treat inflammatory and pruritic manifestations of steroid responsive dermatosis; CALPOL to treat mild to moderate pain; ELTROXIN for hypothyroidism; CCM to treat calcium and vitamin D deficiency; NEOSPORIN for treatment of specific bacterial skin infections; BETNOVATE for skin conditions; T-BACT for bacterial skin infections; and PHYSIOGEL for dry skin associated with redness and itch. The company was formerly known as SmithKline Beecham Pharmaceuticals India Ltd. and changed its name to GlaxoSmithKline Pharmaceuticals Limited in 2001. GlaxoSmithKline Pharmaceuticals Limited was incorporated in 1924 and is headquartered in Mumbai, India.
Pfizer Limited
Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.
N/A
Sanofi Consumer Healthcare India Limited operates as a fast-moving consumer healthcare company in India. It offers products in the allergy, physical wellness, and pain care segments under brands, such as Allegra, Combiflam, Avil, DePURA, Festal, and Novalgin NU through distributors, wholesalers, government institutions and hospitals, pharmacies, pharmacy chains, and e-commerce. The company was incorporated in 2023 and is based in Mumbai, India. Sanofi Consumer Healthcare India Limited operates as a subsidiary of Sanofi India Limited.
SMS Pharmaceuticals Limited
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and its intermediates in India and internationally. The company offers anti-retroviral, anti-inflammatory, anti-viral, anti-diabetic, anti-fungal, anti-epileptic, anti-migraine, anti-coagulant, anti-psychotic, anti-aginal, and anti-ulcer products. It is also involved in contract research activities on peptides. The company exports its products to approximately 75 countries. SMS Pharmaceuticals Limited was incorporated in 1987 and is headquartered in Hyderabad, India.
Start Investing Today
Use a demat account and trading account to start buying or selling stocks in the stock market. Compare share prices and analyze financial statements to make informed investment decisions.
You May Be Interested In
Sanofi India Limited
Healthcare • Drug Manufacturers - General
Marksans Pharma Limited
Healthcare • Drug Manufacturers - General
SENORES
Healthcare • Drug Manufacturers - General
TTK Healthcare Limited
Healthcare • Drug Manufacturers - General
Kopran Limited
Healthcare • Drug Manufacturers - General
NGL Fine-Chem Limited
Healthcare • Drug Manufacturers - General